As our older patient population grows more diverse, it will become increasingly important to understand how to best communicate with patients, and their families, about values and expectations. In addition, teams of medical providers come from different backgrounds, so good dialogue within the team is crucial to providing quality care to patients. What should we keep in mind when caring for our older patients, who may be from cultures than our own? Dr. Alan Abrams, assistant professor of medicine at Harvard Medical School, emphasizes that the skills of ethnogeriatric communication are learnable, teachable and paramount to medicine. Dr. Eric Tangalos hosts.
Ethnogeriatric Considerations: Toward Culturally Sensitive Care

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
As our older patient population grows more diverse, it will become increasingly important to understand how to best communicate with patients, and their families, about values and expectations. In addition, teams of medical providers come from different backgrounds, so good dialogue within the team is crucial to providing quality care to patients. What should we keep in mind when caring for our older patients, who may be from cultures than our own? Dr. Alan Abrams, assistant professor of medicine at Harvard Medical School, emphasizes that the skills of ethnogeriatric communication are learnable, teachable and paramount to medicine. Dr. Eric Tangalos hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?